Titanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 3, 2013, Pages

  Ambalavanan, Namasivayam ^a,b,c   Stanishevsky, Andrei ^b   Bulger, Arlene ^a   Halloran, Brian ^a   Steele, Chad ^d   Vohra, Yogesh ^b   Matalon, Sadis ^a,c,e,f  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

Cytokines; Infant; Inflammation; Metalloproteinase 9; Newborn; Vascular endothelial growth factor (VEGF)

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN 2; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 2; NANOPARTICLE; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LUNG COMPLIANCE; LUNG DEVELOPMENT; LUNG LAVAGE; LUNG RESISTANCE; MACROPHAGE; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CYTOKINES; DOWN-REGULATION; ENDOCYTOSIS; LUNG; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MULTIPLEX POLYMERASE CHAIN REACTION; NANOPARTICLES; PNEUMONIA; RESPIRATORY FUNCTION TESTS; TITANIUM; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84873365984     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00013.2012     Document Type: Article

References (44)

1. Ambalavanan N, Nicola T, Hagood J, Bulger A, Serra R, Murphy-Ullrich J, Oparil S, Chen YF. Transforming growth factor- fj signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 295: L86-L95, 2008.
2. Ambalavanan N, Nicola T, Li P, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63: 26-32, 2008.
3. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, War-heit DB, Everitt JI. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77: 347-357, 2004.
4. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57: 38R-46R, 2005.
5. Bracke KR, Demedts IK, Joos GF, Brusselle GG. CC-chemokine receptors in chronic obstructive pulmonary disease. Inflamm Allergy Drug Targets 6: 75-79, 2007.
6. Bry K, Whitsett JA, Lappalainen U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 36: 32-42, 2007.
7. Burri PH. Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate 89: 313-322, 2006.
8. Chen HW, Su SF, Chien CT, Lin WH, Yu SL, Chou CC, Chen JJ, Yang PC. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 20: 2393-2395, 2006.
9. Chetty A, Cao GJ, Manzo N, Nielsen HC, Waxman A. The role of IL-6 and IL-11 in hyperoxic injury in developing lung. Pediatr Pulmonol 43: 297-304, 2008.
10. Chetty A, Cao GJ, Severgnini M, Simon A, Warburton R, Nielsen HC. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol 295: L584-L592, 2008.
11. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475, 1993.
12. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL, Truog WE. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113: 1709-1714, 2004.
13. Eppert BL, Motz GT, Wortham BW, Flury JL, Borchers MT. CCR7 deficiency leads to leukocyte activation and increased clearance in response to pulmonary Pseudomonas aeruginosa infection. Infect Immunity 78: 2099-2107, 2010.
14. Fedulov AV, Leme A, Yang Z, Dahl M, Lim R, Mariani TJ, Kobzik L. Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. Am J Respir Cell Mol Biol 38: 57-67, 2008.
15. Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18: 565-571, 2007.
16. Geiser M. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 23: 207-217, 2010.
17. Hogmalm A, Sheppard D, Lappalainen U, Bry K. Beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 43: 88-98, 2010.
18. Hougaard KS, Jackson P, Jensen KA, Sloth JJ, Loschner K, Larsen EH, Birkedal RK, Vibenholt A, Boisen AM, Wallin H, Vogel U. Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice. Part Fibre Toxicol 7: 16, 2010.
19. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, Martens JA, Dinsdale D, Boland S, Marano F, Nemery B, Hoet PH. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J 37: 299-309, 2011.
20. Kallapur SG, Jobe AH. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 91: F132-F135, 2006.
21. 2 particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results. Toxicology 264: 110-118, 2009.
22. Lamoureux DP, Kobzik L, Fedulov AV. Customized PCR-array analysis informed by gene-chip microarray and biological hypothesis reveals pathways involved in lung inflammatory response to titanium dioxide in pregnancy. J Toxicol Environ Health 73: 596-606, 2010.
23. Li Y, Li J, Yin J, Li W, Kang C, Huang Q, Li Q. Systematic influence induced by 3 nm titanium dioxide following intratracheal instillation of mice. J Nanosci Nanotechnol 10: 8544-8549, 2010.
24. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med 182: 1301-1314, 1995.
25. Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4: 299-319, 2009.
26. Moreland JG, Fuhrman RM, Pruessner JA, Schwartz DA. CD11b and intercellular adhesion molecule-1 are involved in pulmonary neutrophil recruitment in lipopolysaccharide-induced airway disease. Am J Respir Cell Mol Biol 27: 474-480, 2002.
27. Morimoto Y, Kobayashi N, Shinohara N, Myojo T, Tanaka I, Nakanishi J. Hazard assessments of manufactured nanomaterials. J Occup Health 52: 325-334, 2010.
28. Nicola T, Ambalavanan N, Zhang W, James ML, Rehan V, Halloran B, Olave N, Bulger A, Oparil S, Chen YF. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor--/ agonist rosiglitazone. Am J Physiol Lung Cell Mol Physiol 301: L125-L134, 2011.
29. Nicola T, Hagood JS, James ML, Macewen MW, Williams TA, Hewitt MM, Schwiebert L, Bulger A, Oparil S, Chen YF, Ambalavanan N. Loss of Thy-1 inhibits alveolar development in the newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 296: L738-L750, 2009.
30. Olave N, Nicola T, Zhang W, Bulger A, James M, Oparil S, Chen YF, Ambalavanan N. Transforming growth factor- β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. Am J Physiol Lung Cell Mol Physiol 302: L857-L865, 2012.
31. Park EJ, Yoon J, Choi K, Yi J, Park K. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology 260: 37-46, 2009.
32. Proost P, Wuyts A, Van Damme J. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 59: 67-74, 1996.
33. Sadauskas E, Jacobsen NR, Danscher G, Stoltenberg M, Vogel U, Larsen A, Kreyling W, Wallin H. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Central J 3: 16, 2009.
34. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97: 163-180, 2007.
35. Stone V, Johnston H, Clift MJ. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobiosci-ence 6: 331-340, 2007.
36. Tang M, Zhang T, Xue Y, Wang S, Huang M, Yang Y, Lu M, Lei H, Kong L, Yuepu P. Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles. J Nanosci Nanotechnol 10: 8575-8583, 2010.
37. Thurlbeck WM. Postnatal human lung growth. Thorax 37: 564-571, 1982.
38. Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 19: 333-345, 2008.
39. 2 particle formulations: impact of surface treatments on particle toxicity. Toxicol Sci 88: 514-524, 2005.
40. Warheit DB, Hansen JF, Yuen IS, Kelly DP, Snajdr SI, Hartsky MA. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol Appl Pharmacol 145: 10-22, 1997.
41. 2 particles: differential responses related to surface properties. Toxicology 230: 90-104, 2007.
42. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46: 2242-2250, 2012.
43. White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, Kaiser K, Foley JJ, Schmidt DB, Johanson K, Macphee C, Moores K, McNulty D, Scott GF, Schleimer RP, Sarau HM. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62: 667-675, 1997.
44. Zhao F, Zhao Y, Liu Y, Chang X, Chen C. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7: 1322-1337, 2011.